Lead: Daniel Fologea
Partner: GT Medical Technolgy, Krista Cline, KristaCline@gtmedtech.com; RadRelease, Robert Woodburn, rwoodburn@radrelease.com
Amount: $254388
Intellectual Property Status: Patent
Award Date: 08/01/2024
End Date: 07/31/2026
ABSTRACT
This research project is focused on the development of radiation-sensitive liposomes to be used for concomitant and localized radio- and chemotherapy treatment of solid tumors. Our patented technology is anticipated to mitigate the sequels associated with systemic therapy and substantially improve the clinical outcome for cancer patients.
This is not the NSF website for the ART program. The development of this portal is supported by the U.S. National Science Foundation under Award No. 2331429. The material on this portal is sourced from the various activities and projects being supported the ART program. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the U.S. National Science Foundation.
